SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 79 filers reported holding SERES THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $822 | -50.3% | 345 | 0.0% | 0.00% | – |
| Q2 2023 | $1,653 | -15.5% | 345 | 0.0% | 0.00% | – |
| Q1 2023 | $1,957 | +1.3% | 345 | 0.0% | 0.00% | – |
| Q4 2022 | $1,932 | -3.4% | 345 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | +100.0% | 345 | +72.5% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 200 | +174.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 73 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | -50.0% | 73 | 0.0% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 73 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 73 | -27.0% | 0.00% | – |
| Q4 2020 | $2,000 | -33.3% | 100 | 0.0% | 0.00% | – |
| Q3 2020 | $3,000 | +50.0% | 100 | -71.4% | 0.00% | – |
| Q2 2020 | $2,000 | 0.0% | 350 | -50.0% | 0.00% | – |
| Q1 2020 | $2,000 | – | 700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 12,682,876 | $143,316,000 | 50.54% |
| ARK Investment Management | 765,191 | $8,647,000 | 1.68% |
| Rock Springs Capital Management LP | 220,000 | $2,486,000 | 0.13% |
| Artal Group S.A. | 600,000 | $6,780,000 | 0.12% |
| Virtus ETF Advisers LLC | 29,324 | $331,000 | 0.05% |
| FEDERATED HERMES, INC. | 748,568 | $8,459,000 | 0.02% |
| PDT Partners, LLC | 25,500 | $288,000 | 0.01% |
| Baker Brothers Advisors | 125,000 | $1,413,000 | 0.01% |
| D. E. Shaw & Co., Inc. | 527,261 | $5,958,000 | 0.01% |
| FMR LLC | 6,056,294 | $68,436,000 | 0.01% |